|
|
|
|
||
PharmaTechnologist: MannKind: Small step for delivery tech R&D after Afrezza's giant leapMannKind: Small step for delivery tech R&D after Afrezza's giant leap By Dan Stanton+, 19-Jan-2015 MannKind’s development of new drugs with the delivery technology used in its inhalable insulin drug Afrezza will progress without founder Alfred Mann at the helm. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
8516 | Re: Sanofi's Big Bet on Integrated Patient Care | eagle76 | 0 | 1/19/2015 6:35:08 PM |